FOXM1 and neoplasm: Other preclinical studies using INS-1 tumour-bearing mice have shown that GLP-1 receptor targeting ligands, labeled either with 111In, 68Ga or 18F, show a more favorable biodistribution compared to this maxadilan tracer.